ROLITE COMPANY, INC. – Trademark Portfolio
Entity Type: 03
ROLITE COMPANY, INC. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 12 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include BON VITAL', OPTI GLOSS, THERAPEUTIC TOUCH, WELLNESS FOR THE FEET, and WELLNESS FOR THE SKIN. The owner is based in Hartland, WI.
596 Progress Drive
Hartland, WI 53029
Showing of trademarks Trademarks
Trademark Classifications
ROLITE COMPANY, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ROLITE COMPANY, INC. have?
ROLITE COMPANY, INC. has 15 U.S. trademarks filed with the USPTO. Of these, 6 registered, 6 abandoned, 3 cancelled.
What trademark classes does ROLITE COMPANY, INC. file in?
ROLITE COMPANY, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are ROLITE COMPANY, INC.'s most well-known trademarks?
ROLITE COMPANY, INC.'s registered trademark portfolio includes well-known marks such as BON VITAL', OPTI GLOSS, THERAPEUTIC TOUCH, WELLNESS FOR THE FEET, and WELLNESS FOR THE SKIN. These are among 6 currently registered trademarks in the portfolio.
What is ROLITE COMPANY, INC.'s trademark registration success rate?
ROLITE COMPANY, INC. has a 40% trademark registration rate, with 6 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.